Table 1.
Lab 1 | Lab 2 | Lab 3 | Lab 4 | Lab 5 | Lab 6 | Lab 7 | Lab 8 | Lab 9 | Lab 10 | Lab 11 | Lab 12 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Region | Urban | Urban | Urban | Urban | Urban | Urban | Urban | Urban | Urban | Urban | Urban | Urban |
Corporation zone | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 8 | 8 | 9 |
Health facility | PHC | PHC | PHC | PHC | PHC | PHC | DTC | PHC | GPH | Research centre | PHC | PHC |
Diagnostic facility | DMC | DMC | DMC | DMC | DMC | DMC | DMC | DMC | DMC | IRL | DMC | DMC |
Year of assessment | 2019 | 2019 | 2019 | 2019 | 2019 | 2019 | 2019 | 2019 | 2019 | 2019 | 2019 | 2019 |
Population covered | 50 633 | 50 700 | 50 596 | 50 680 | 54 730 | 50 892 | 215 434 | 50 320 | 152 047 | NA | 229 390 | 182 362 |
Persons requiring test for TB/month | 79 | 88 | 108 | 66 | 37 | 45 | 350 | 71 | 147 | NA | 230 | 268 |
Diagnostic test available | ZN microscopy | ZN microscopy | ZN microscopy | ZN microscopy | ZNmicroscopy | ZN microscopy | ZN microscopyFM Gene Xpert MTB/RIFx-ray | ZN microscopy | ZN microscopyDigital x-ray | MGITDigital X-rayX-rayZN microscopyFM Gene XpertMTB/RIFLPALJ culture | ZN microscopyGene Xpert MTB/RIF | ZN microscopyGene Xpert MTB/RIF |
Data collected | ZN microscopy | ZN microscopy | ZN microscopy | ZN microscopy | ZN microscopy | ZN microscopy | FM Gene Xpert MTB/RIFx-ray | ZN microscopy | ZN microscopyDigital x-ray | Gene Xpert MTB/RIFMGITLPALJ culture | Gene Xpert MTB/RIF | Gene Xpert MTB/RIF |
Abbreviations: DMC, designated microscopy centres; DTC, district TB centre; FM, fluorescence microscopy; Gene Xpert, cartridge-based nucleic acid amplification test (NAAT) that identifies rifampicin resistant Mycobacterium Tuberculosis; GPH, government peripheral hospital; IRL, intermediate reference laboratory; LJ, Lowenstein Jensen; LPA, line probe assay; MGIT, mycobacteria growth indicator tube; MTB/RIF, Mycobacterium Tuberculosis/Rifampicin; PHC, primary health centre; ZN, Ziehl–Neelsen microscopy.